Key Takeaways
- A class‑action lawsuit filed in California accuses Trader Joe’s of misleadingly marketing its French Roast Low‑Acid whole‑bean coffee as fully caffeinated when it contains roughly half the caffeine of a regular blend.
- Plaintiffs argue that because Trader Joe’s did not disclose the reduced caffeine level, consumers purchased the product under the false impression they were getting a standard‑strength coffee.
- The suit cites industry practice: only coffees that have undergone a caffeine‑reduction process (e.g., “decaf” or “half‑caff”) are required to label their caffeine content; regular caffeinated coffee normally carries no such disclaimer.
- The plaintiffs contend that the mislabeling influenced purchasing decisions, as many coffee drinkers rely on caffeine for daily energy and would not have bought—or would have paid less for—a product they knew was low‑caffeine.
- They are seeking monetary damages and an injunction to stop Trader Joe’s from selling the coffee under its current labeling, demanding clearer disclosure of caffeine levels.
Trader Joe’s, the popular grocery chain known for its private‑label offerings, is facing legal scrutiny over one of its coffee products. Four customers who bought the retailer’s French Roast Low‑Acid whole‑bean coffee have filed a class‑action complaint in a California federal court, alleging that the company’s packaging and advertising led them to believe the coffee contained a typical amount of caffeine, when in fact independent testing shows it delivers only about half the caffeine found in a standard brew.
According to the plaintiffs’ attorneys, the core of the deception lies in Trader Joe’s failure to indicate any special labeling that would alert shoppers to the reduced caffeine content. In the coffee industry, it is customary to highlight caffeine levels only when a product has undergone a process that deliberately lowers its caffeine—such as decaffeination or blending to create a “half‑caff” version. Regular, fully caffeinated coffees are generally sold without any caffeine‑specific disclaimer, under the assumption that they contain the normal range of stimulant. By not labeling its French Roast Low‑Acid as a low‑caffeine product, Trader Joe’s allegedly allowed consumers to assume they were purchasing a standard‑strength coffee.
The lawsuit emphasizes how integral caffeine is to many consumers’ daily routines. The complaint notes that coffee drinkers often depend on the stimulant to “get through the day,” making caffeine concentration a significant factor in purchase decisions. If a shopper knows a blend is low‑caffeine, they might opt for a different product or expect a lower price point, mirroring the pricing differential seen between regular and half‑caff offerings. Because the Trader Joe’s coffee was marketed without any indication of its reduced caffeine level, the plaintiffs claim they paid a premium for a product that did not deliver the expected stimulant effect, thereby suffering economic harm.
In their filing, the plaintiffs request both compensatory damages—reimbursement for the alleged overpayment—and punitive damages to deter similar conduct. They also ask the court to issue an injunction prohibiting Trader Joe’s from continuing to sell the French Roast Low‑Acid coffee under its current labeling until the retailer provides clear, accurate information about its caffeine content on the packaging.
As of the filing date, Trader Joe’s has not issued a public response to CBS News’ request for comment. The case adds to a growing trend of consumer protection lawsuits targeting food and beverage manufacturers for alleged misleading labeling, particularly around health‑related attributes such as caffeine, sugar, or allergens. If the court certifies the class and finds in favor of the plaintiffs, the outcome could prompt broader changes in how coffee brands disclose caffeine levels, potentially requiring more explicit labeling even for products that are not explicitly marketed as decaffeinated or low‑caffeine.
The lawsuit underscores the importance of transparency in food labeling, especially for ingredients that directly affect consumer physiology and purchasing behavior. While Trader Joe’s maintains a reputation for offering high‑quality, value‑driven products, this legal challenge highlights how even well‑intentioned product lines can run afoul of consumer expectations when key nutritional information is omitted or unclear. As the case progresses, it will be watched closely by both industry stakeholders and advocacy groups seeking stricter labeling standards for caffeinated beverages.

